checkAd

     173  0 Kommentare Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting

    • A sponsored session will feature Dr. Alex Hastie from Bionano, Dr. Suk See De Ravin from National Institute of Health (NIH) and Travis Hardcastle from Synthego presenting on the utility of optical genome mapping (OGM) across cell and gene therapy research, development and manufacturing applications

    SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the International Society for Stem Cell Research (ISSCR) Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping (OGM) for research, development, and manufacturing applications in stem cell therapy. ISSCR’s annual meeting brings together industry, medical, and academic professionals to discuss advances in stem cell research and regenerative medicine. The ISSCR conference will be held June 14-17, 2023, online and in-person in Boston, Massachusetts.

    As part of a sponsored session titled “Optical Genome Mapping - Redefining Cell Line Genomic Integrity and Off-target Characterization,” three experts will share their experiences using OGM in their research, development and manufacturing processes. Presentations will cover OGM’s utility for monitoring genomic integrity and off-target effects in cell lines and its potential to improve the quality, safety, and overall risk profile of next-generation therapy development and manufacturing. Dr. Alex Hastie (Bionano), Dr. Suk See De Ravin from National Institute of Health (NIH) and Travis Hardcastle from Synthego will present in Room 255 on Friday, June 16, 2023, at 11:30 am ET.

    A scientific poster by Dr. Andy Pang from Bionano, covering the use of OGM in cell manufacturing and bioprocessing applications, will be on display during the conference.

    Session   Title Presenter   Presented
    Sponsored
    Session
      Optical Genome Mapping - Redefining cell line genomic integrity and off-target characterization
    Hastie A., De Ravin S., Hardcastle T.   June 16, 2023

    11:30-12:30 PM ET

    Room 255, Level 2


    Poster Number Title Author
    923 Genome Integrity Assessment and Verification by Optical Genome Mapping for Cell Manufacturing/Bioprocessing Applications​ Pang A.
    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting A sponsored session will feature Dr. Alex Hastie from Bionano, Dr. Suk See De Ravin from National Institute of Health (NIH) and Travis Hardcastle from Synthego presenting on the utility of optical genome mapping (OGM) across cell and gene therapy …

    Schreibe Deinen Kommentar

    Disclaimer